dhbuzz Tuesday, 09/15/20 10:58:07 AM Re: None Post # of 2640 Just a reminder...The next FMFX response from FDA will be virtual,not written. Zynerba has been notified that the U.S. Food and Drug Administration (FDA) will meet with the Company via teleconference in the fourth quarter of 2020 to discuss the pivotal CONNECT-FX data and the regulatory path forward in patients with FXS and a fully methylated FMR1 gene (FMet). The Company also expects to disclose the outcome of the meeting in the fourth quarter of this year.